Legal Entity
Insights
LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.
Last Updated: 27 Aug 2026
At LGC we offer a full range of high quality PCR reagents, custom genotyping assays, genomic services and workflow solutions for DNA sample preparation and downstream processing (www.lgcgroup.com/genomics).
Our proprietary KASP™ allelic discrimination chemistry and has optimised workflows for 1536 microtitre plates that enable assay miniaturization for more flexible, cost effective workflow solutions in high throughput genotyping. In addition, customers are offered industry leading proprietary nucleic acid extraction, sequencing and genotyping services from our laboratories in Europe and US.
Key applications include validation and screening of newly discovered SNPs in Marker-Assisted Selection and Marker-Assisted Breeding programmes for both plant and livestock. As such, the company is building a leading position in the agbio market and increasing adoption by the academic research market, with over 1700 scientific papers citing KASP.
We operate sales offices in the UK, Germany and the USA, with sales representatives throughout Europe and Australia as well as distributors in China, Korea and other key emerging territories.
Country of registration | Singapore |
Registration number | 201117024H |
Local SIC | |
Incorporation date | 18 Jul 2011 |
Company age | 15 years 1 month |
Official entity type | Private Limited Company |
No. of officers | 11 |
Contact
Address:
1 HARBOURFRONT AVENUE, #14-07, KEPPEL BAY TOWER, Singapore 098632
Access Key Decision Makers
This is the legal entity page of LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- LGC GENOMICS DIVISIONView MoreGermanyAt LGC we offer a full range of high quality PCR reagents, custom genotyping assays, genomic services and workflow solutions for DNA sample preparation and downstream processing (www.lgcgroup.com/genomics). Our proprietary KASP™ allelic discrimination chemistry and has optimised workflows for 1536 microtitre plates that enable assay miniaturization for more flexible, cost effective workflow solutions in high throughput genotyping. In addition, customers are offered industry leading proprietary nucleic acid extraction, sequencing and genotyping services from our laboratories in Europe and US. Key applications include validation and screening of newly discovered SNPs in Marker-Assisted Selection and Marker-Assisted Breeding programmes for both plant and livestock. As such, the company is building a leading position in the agbio market and increasing adoption by the academic research market, with over 1700 scientific papers citing KASP. We operate sales offices in the UK, Germany and the USA, with sales representatives throughout Europe and Australia as well as distributors in China, Korea and other key emerging territories.
- LGCView MoreUnited Kingdom of Great Britain and Northern IrelandLGC is a global leader in life sciences, diagnostics and analytical solutions. We work with partners around the world to address some of society’s most important challenges, from diagnosing disease and enabling new treatments to supporting food security and protecting public health. Our science underpins discovery, enables better health outcomes and helps safeguard the integrity of food, water, medicines and the environment. Every day, we provide the components, standards and services that laboratories, manufacturers and regulators rely on to make confident, evidence-based decisions. With operations in 14 countries and more than 180 years of scientific expertise, our work supports public health and sustainability at a global scale. From improving the accuracy of medical testing and verifying the safety of food products, to helping scientists develop the next generation of medicines, our solutions are trusted by customers in more than 170 countries.
This is the legal entity page of LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | January - March |
Auditor | ERNST & YOUNG LLP |
Revenue | 1m - 5m |
Financial period end date | 31 Mar 2022 |
Share Capital - Ordinary shares | SGD 1 |
Share Capital - Ordinary shares | GBP 5,330,500 |
Last updated: 27 Aug 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.?
- Where is LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.'s headquarter?
- What is LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.'s contact number?
- What LGC SCIENCE GROUP (SINGAPORE) PTE. LTD.'s spending power?
- Does LGC SCIENCE GROUP (SINGAPORE) PTE. LTD. have a presence in the domain it operates in?